New imaging for heart muscle damage after a heart attack
Part of Heart & circulation clinical trials.
This study uses special imaging scans (MRI and PET) to look at the health of the heart muscle in people with advanced heart failure caused by blocked arteries. The goal is to better predict recovery after bypass surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have advanced heart failure (left ventricle ejection fraction less than 40%) caused by blocked arteries.
- You are scheduled for coronary artery bypass surgery (CABG).
- You must be able to have an MRI and PET scan (no metal implants or strong claustrophobia).
- If you are a woman able to have children, a negative pregnancy test is required on scan day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI scan to look at heart muscle metabolism in people with heart failure caused by blocked arteries. It may help doctors better understand which heart tissue is still alive and could recover.
This study tests a special heart scan that measures blood flow to the heart muscle. It may help doctors decide if your heart blockages need treatment or if medication is enough.
This study looks at tiny structures inside heart muscle cells (especially “power stations” in the cells) in people with certain types of heart failure who are getting coronary bypass surgery. It may help researchers better understand what changes happen in the heart and how this could guide future care.
This study uses two imaging scans to see if parts of your heart muscle are still alive but not working well. This could help doctors decide if you might benefit from heart bypass surgery.
This study uses a special imaging test (PET/MR) to check if damaged heart muscle is still alive and can recover. It is for people with severe blocked arteries and weak heart pumping function who are planning bypass surgery or stem cell treatment.
This study uses a special imaging agent to see a protein called PDGFRß in the heart, which may help detect scarring (fibrosis) after a heart attack or in heart failure. It aims to improve how we understand and treat heart muscle damage.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.